Cargando…
Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial
OBJECTIVE: To examine the efficacy of weight‐adjusted D‐cycloserine (DCS) (35 or 70 mg) relative to placebo augmentation of intensive exposure therapy for youth with obsessive‐compulsive disorder (OCD) in a double‐blind, randomised controlled trial, and examine whether antidepressant medication or p...
Autores principales: | Farrell, Lara J., Waters, Allison M., Tiralongo, Evelin, Mathieu, Sharna, McKenzie, Matthew, Garbharran, Vinay, Ware, Robert S., Zimmer‐Gembeck, Melanie J., McConnell, Harry, Lavell, Cassie, Cadman, Jacinda, Ollendick, Thomas H., Hudson, Jennifer L., Rapee, Ronald M., McDermott, Brett, Geller, Daniel, Storch, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303435/ https://www.ncbi.nlm.nih.gov/pubmed/35084071 http://dx.doi.org/10.1002/da.23242 |
Ejemplares similares
-
D‐cycloserine‐augmented one‐session treatment of specific phobias in children and adolescents
por: Farrell, Lara J., et al.
Publicado: (2018) -
D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis
por: Xia, Jing, et al.
Publicado: (2015) -
D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis
por: Bürkner, Paul-Christian, et al.
Publicado: (2017) -
PT623. A Meta-Analysis of D-Cycloserine Influence ofCognitive-Behavioral Therapy in Obsessive-Compulsive Disorder
por: Gu, Wenjie, et al.
Publicado: (2016) -
Cognitive Beliefs Across the Symptom Dimensions of Pediatric Obsessive-Compulsive Disorder: Type of Symptom Matters
por: Cervin, Matti, et al.
Publicado: (2022)